About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

NCT00161681·48 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18–49

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Healthy women aged 18 to 49 years
Regular 21 to 35 day menstrual cycles for 3 months prior to study visit 1
History of menstrual cycle related symptoms as determined by the investigator.

You may not be if

Contraindication to combination oral contraceptives
Depression requiring hospitalization or associated with suicidal ideation within the last 3 years
Use of antidepressants/anxiolytics within 10 days of screening and for the duration of the study.

The record

StatusCompleted

PhasePhase 3

Taking part200

StartedJul 2005

UpdatedFeb 8, 2013

Conditions

Premenstrual Syndrome

Where48

Huntsville, Alabama, United States
Peoria, Arizona, United States
Phoenix, Arizona, United States

Clareo Health | Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS